Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men
- 31 January 2001
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 110 (1) , 22-27
- https://doi.org/10.1016/s0002-9343(00)00652-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysisNature Medicine, 1995
- Apolipoproteins and ischaemic heart disease: implications for screeningThe Lancet, 1994
- Lipoprotein(a) and AtherosclerosisAnnals of Internal Medicine, 1991
- Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjectsAtherosclerosis, 1991
- Thrombogenesis linked to atherogenesis at last?Nature, 1989
- A potential basis for the thrombotic risks associated with lipoprotein(a)Nature, 1989
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study.Journal of Epidemiology and Community Health, 1985
- MYOCARDIAL ISCHÆMIA, RISK FACTORS AND DEATH FROM CORONARY HEART-DISEASEThe Lancet, 1977